Agenda

Return

C. 71

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	February 1, 2022

Contra

Costa

County

Subject:

Purchase Order with Cepheid, Inc.

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 02/01/2022

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Jaspreet Benepal, 925-370-5101
cc:	Marilyn Bybee

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: February 1, 2022
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent to execute, on behalf of the Health Services Director, a purchase order with Cepheid, Inc. in an amount not to exceed $970,190 for the purchase of reagents and supplies for COVID-19 testing for the Clinical Laboratory at the Contra Costa Regional Medical Center (CCRMC) and Contra Costa Health Center, for the period from January 15, 2022 through January 14, 2023.

FISCAL IMPACT:

Approval of this contract will result in annual expenditures of up to $970,190 over a one-year period and will be funded 100% by American Rescue Plan Act through the Hospital Enterprise Fund I.

BACKGROUND:

The CCRMC Clinical Laboratory on November 24, 2020, began performing Cepheid, XPRESS, COV-2/FLU/RSV testing as it provides rapid detection of the current coronavirus. This test can be processed in 25 minutes for a positive result and provide results for all four pathogens in just 36 minutes with less than a minute of hands-on time. Utilization of this rapid detection test will create capacity for our staff and enable them to manage their increased workload effectively and efficiently which has been created by the growing demand for COVID-19 testing.

The supplies requested for purchase are propriety to our Cepheid GeneXpert Xpress system.

CONSEQUENCE OF NEGATIVE ACTION:

If this purchase order is not approved, then the CCRMC Clinical Laboratory will not be able to perform the specific COVID-19 patient testing that utilizes these supplies thus impacting patient safety and health.